TSXV:VIV.H - Post by User
Post by
MineDiggeron Feb 22, 2013 8:42am
![](https://assets.stockhouse.com/kentico-cms/0341-00/images/Sprite.svg#id_Post_Views_Icon)
149 Views
Post# 21027614
Outlook
Outlook So having lost a little in 2010/11 when TechnicalBuy had this (CFR) as a pick, I'm curious about the 60-70c mentioned of late:
- "Ultimately, I agree with the 60-70 cent target [jdstox]. I'd say December 2013 for that, but it's just a guess. " [smallcaplover]
- "The company update at the end of January did not indicate to me that anything regarding their products were going to come to fruition this year." [woundedknee]
- "With successful completion of current partnership initiatives in international markets, we have targeted breakeven in 2013 and profitability in 2014." [David Hankinson CEO on stockhouse (as client), 2012-03-08]
2012 ended with 96.7 + 40.5 shares, implying 2013 ending with 80-100m cap and the CEO not yet expecting to be making a profit (and who ever arrives on time with financial+s).
Isn't this valuation going to take a lot of collective belief in future rather than past performance. And how much cash will have to be raised before (or after) cf+?
But I can see that antibiotic growth promotion alternatives look attractive, not an area I understand though, and I thought they had already been banned.
MD